SciELO - Scientific Electronic Library Online

 
vol.21 suppl.3Consecuencias clínicas de la sarcopeniaParticularidades fisiopatológicas de las alteraciones musculares en el paciente con EPOC índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

BURGOS PELAEZ, R.. Global therapeutica approach to sarcopenia. Nutr. Hosp. [online]. 2006, vol.21, suppl.3, pp.51-60. ISSN 1699-5198.

Sarcopenia is the loss of skeletal muscle mass that occurs with ageing, and is a major contributing factor to disability and loss of independence in the elderly. The etiopathogenesis involves a number of underlying mechanisms including intrinsic changes in the muscle and central nervous system, and hormonal and lifestyle factors. Many hormones and cytokines affect muscle mass and function. Reductions in testosterone and estrogens that accompany ageing appear to accelerate loss of muscle mass. Growth hormone has been hypothesised to contribute to loss of lean body mass. Although sarcopenia is not completely reversed with exercise, physical inactivity leads to accelerated muscle loss. The diagnosis of sarcopenia is difficult because the most reliable methods to measure muscle mass are not easily available. Various treatment strategies have been tested for combating the loss of muscle mass: testosterone replacement and other anabolic androgens for men, estrogen replacement in women, growth hormone replacement, nutritional treatment and physical training. Only high resistance exercise training has been effective in increasing muscle mass, with or without nutritional supplementation.

Palabras clave : Sarcopenia; Ageing; Muscular atrophy.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons